Overview
Rocket Lab USA, Inc., based in the United States, operates primarily in the aerospace sector with a focus on manufacturing and launching small satellites. Founded with the aim of providing frequent and reliable access to orbit, the company specializes in tailored launch services that cater to the commercial, government, and defense industries. Key projects include the Electron small orbital rocket and the Photon spacecraft platform, both integral to Rocket Lab’s strategy of reducing the cost and complexity of accessing space. Furthermore, the company is known for pioneering recoverable rocket technologies, aiming to enhance sustainability in its launch operations. This innovative approach ensures Rocket Lab remains at the forefront of the burgeoning small satellite launch market.
AI+ Ask Fintel’s AI assistant about Rocket Lab Corporation.
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Rocket Lab Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 8.65 MM |
| Earnings Date | |
| EPS (TTM) | -6.36 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.10 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | -0.28 |
| ROE | -0.40 |
| ROIC | -0.39 |
| CROIC | -0.31 |
| OCROIC | -0.23 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 4.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Rocket Lab Corporation is MX$857.58. The forecasts range from a low of MX$378.47 to a high of MX$1,082.01. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Rocket Lab Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-05-13 | Needham | Buy | Buy | Reiterate |
| 2025-05-12 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-04-25 | Needham | Buy | Initiate | |
| 2025-07-16 | B of A Securities | Buy | Buy | Maintains |
| 2025-03-14 | Citizens Capital Markets | Market Perform | Market Perform | Reiterate |
| 2025-03-10 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-03 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-28 | Keybanc | Overweight | Overweight | Maintains |
| 2025-02-28 | Citigroup | Buy | Buy | Maintains |
| 2025-01-29 | Keybanc | Overweight | Overweight | Maintains |
| 2025-01-21 | Citigroup | Buy | Buy | Maintains |
| 2025-01-16 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-01-08 | Stifel | Buy | Buy | Maintains |
| 2024-12-11 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-19 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-11-18 | Citigroup | Buy | Buy | Maintains |
| 2024-11-14 | B of A Securities | Buy | Buy | Maintains |
| 2024-11-14 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-11-13 | Stifel | Buy | Buy | Maintains |
| 2024-11-13 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-06 | Citigroup | Buy | Buy | Maintains |
| 2024-10-24 | Keybanc | Overweight | Overweight | Maintains |
| 2024-10-10 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-09-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-09-27 | Keybanc | Overweight | Overweight | Maintains |
| 2024-09-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-09-12 | JMP Securities | Market Perform | Initiate | |
| 2024-09-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-09-03 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-14 | Citigroup | Buy | Buy | Maintains |
| 2024-07-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-15 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2024-07-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-26 | BTIG | Neutral | Initiate | |
| 2024-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-18 | Roth MKM | Buy | Buy | Maintains |
| 2024-06-11 | Goldman Sachs | Neutral | Initiate | |
| 2024-05-28 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-05-07 | Citigroup | Buy | Buy | Maintains |
| 2024-04-04 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-12 | Citigroup | Buy | Reiterate | |
| 2024-01-17 | Keybanc | Overweight | Initiate | |
| 2023-12-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-26 | Cantor Fitzgerald | Overweight | Initiate | |
| 2023-09-27 | TD Cowen | Outperform | Outperform | Maintains |
| 2023-09-27 | Roth MKM | Buy | Buy | Reiterate |
| 2023-09-27 | Stifel | Buy | Buy | Maintains |
| 2023-09-20 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-09-19 | Roth MKM | Buy | Buy | Reiterate |
| 2023-08-09 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-09 | Citigroup | Neutral | Neutral | Maintains |
| 2023-04-18 | Citigroup | Neutral | Initiate | |
| 2023-03-07 | Deutsche Bank | Buy | Maintains | |
| 2023-03-06 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-11-14 | Deutsche Bank | Buy | Maintains | |
| 2022-11-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-11-10 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-10-12 | Credit Suisse | Underperform | Initiate | |
| 2022-08-31 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2022-08-17 | Stifel | Buy | Maintains | |
| 2022-08-16 | Morgan Stanley | Overweight | Maintains | |
| 2022-08-15 | Deutsche Bank | Buy | Maintains | |
| 2022-06-21 | Wells Fargo | Equal-Weight | Initiate | |
| 2022-05-18 | Morgan Stanley | Overweight | Maintains | |
| 2022-05-17 | Deutsche Bank | Buy | Maintains | |
| 2022-03-01 | Stifel | Buy | Maintains | |
| 2022-02-23 | Roth Capital | Buy | Initiate | |
| 2022-01-12 | Morgan Stanley | Overweight | Initiate | |
| 2021-11-30 | B of A Securities | Buy | Initiate | |
| 2021-09-30 | Stifel | Buy | Initiate | |
| 2021-09-17 | Deutsche Bank | Buy | Initiate | |
| 2021-09-13 | Cowen & Co. | Market Perform | Initiate | |
| 2021-09-09 | Canaccord Genuity | Buy | Initiate | |
| 2025-05-28 | Needham | Buy | Buy | Maintains |
| 2025-05-28 | Stifel | Buy | Buy | Maintains |
| 2025-05-28 | Roth Capital | Buy | Buy | Maintains |
| 2025-07-02 | Keybanc | Overweight | Overweight | Maintains |
| 2025-08-08 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2025-08-08 | Keybanc | Overweight | Overweight | Maintains |
| 2025-08-08 | Needham | Buy | Buy | Maintains |
| 2025-07-14 | Citigroup | Buy | Buy | Maintains |
| 2025-09-03 | Needham | Buy | Buy | Reiterate |
| 2025-04-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-10 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2025-08-05 | Stifel | Buy | Buy | Maintains |
